Data from 2020-2021, Estimates to 2022, and CAGR Forecasts to 2027

DUBLIN, August 26, 2022 /PRNewswire/ — The “Human Reproductive Technologies: Global Products and Markets” report has been added to’s The offer of

Search_and_markets logo

Increased investment and advances in each of the three key areas of infertility, contraception and sexual dysfunction.

The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographical scope of the report is global. The report examines male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies related to reproductive health. The report also explores the market size, identifies market participants and investigates pipeline products and technologies.

Many factors affect the human reproductive arena. Countries differ in approaches to and acceptance of fertility, contraception and sexual dysfunction. Culture, religion and social environment all play a role; depending on a woman’s place and position in society, it can make a big difference in how reproduction is treated.

The choice of contraception varies by country: in Japan, condoms and abortions are preferred over other methods; IN India, sterilization is the preferred method of birth control; IN China, the use of the coil is preferred; while in Africa, injectable birth control prevails. This difference in preference by country is also seen in the fields of fertility and sexual dysfunction.

One of the most popular, well-known and, at the time, most controversial medical points in this area is the use of assisted reproductive technology (ART) to manage infertility. Recent developments in the field of ART have intensified the hopes and desires of infertile people to resolve their infertility, resulting in a growing demand for such services in both developed and developing countries.

While the developments in RTSH have evolved rapidly, so have the ethical, social and political controversies that surround almost all aspects of RTSH. Few other fields in medicine have raised so many social and ethical questions and attracted so much public attention. Cultural differences affect the acceptance of RTSH.

Additionally, economic forces play a role in this market because it is an expensive venture that is not affordable for many. In Asia, the doors appear to be opening for growth, but there are hurdles to overcome, such as educating doctors and patients about social and cultural procedures and customs that influence ART.

New developments in the field of contraception have increased the search for easier, safer and more convenient methods of contraception. There is no miracle drug or method of contraception, but scientists are pursuing several avenues of discovery to create better options for individuals.

Sexual dysfunction is now a disorder accepted by the general public and the medical community. Before the advent of Viagra, the disorder was present but unacknowledged and largely untreated. The introduction of Viagra opened a Pandora’s box in the development of sexual dysfunction drugs and devices for both sexes, at a time when female sexual dysfunction was virtually unknown.

This area of ​​reproductive health is filled with opportunities for research and discovery and will likely continue to advance over the next few years, but progress has been slow and few ED products are open to general development.

Descriptive company profiles of major global players including Actavis, Inc., Bayer AG, EMD Serono, Inc. and Quidel Corp.

The report includes

  • Analysis of Global Market Trends, with Data from 2020-2021, Estimates to 2022, and Compound Annual Growth Rates (CAGR) Forecasts to 2027

  • Overall market size estimation and forecast, projected growth trends and corresponding market share analysis by treatment type, disease indication, end-user vertical and geographic region

  • In-depth information (facts and figures) about market drivers, market barriers and other demographic and economic factors influencing the progress of this reproductive health market

  • Discussion of emerging technology trends, market opportunities and gaps assessing current and future demand for reproductive medicine and technology, and the implications of COVID-19 within the market

  • Identifying promising new products and technologies still in the development and pipeline stage, and assessing the probability that they will be successfully commercialized in the next five years

  • Company competitive landscape review of the global human reproductive drugs market, their product portfolios, global ranking and company value share analysis based on segmental revenue

  • Major merger and acquisition agreements, new product launches and other strategic alliances within the industry

  • A relevant patent analysis

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Industry overview

  • The structure and function of the reproductive system

  • man


  • Neuroendocrine regulation

  • Menarche

  • Menstrual cycle

  • Stages of sexual responses

  • Male sexual response

  • Female sexual response

  • Neurohormonal control of the female and male reproductive system

  • Effects of aging

  • Reproductive health issues and trends

  • Contraceptive insurance

  • Non-prescription birth control pills

  • Genetic diagnosis before implantation

  • Designer baby

  • New use for contraceptives

  • Aging and Sterility

  • Death from the contraceptive patch

  • Sexual dysfunction and cancer

  • Infertility and Cancer

  • The signaling pathway for fertility treatment

  • Marketing tactics

  • Male birth control

  • Merchandising targeting women

  • Counterfeit products

  • Excess embryos and fetuses

  • Stem cells and other controversial issues – Selected international perspectives

  • The controversial destruction of embryos

  • Demography

Chapter 4 The Infertility Market

Chapter 5 Impact of Covid-19

  • presentation

  • Covid-19: Impact on the medical device and pharmaceutical industries

  • Decline/Delay in election procedures

  • The impact of Covid-19 on the supply chain

  • The US Supply Chain: The Impact of Covid-19

  • The European Supply Chain: Impact of Covid-19

  • Apac Supply Chain: Impact of Covid-19

  • China: Impact of Covid-19

  • The impact of Covid-19 on the medical device and pharmaceutical product segments

  • Impact of Covid-19 on critical equipment

  • Impact of Covid-19 on human reproductive technologies and product markets

Chapter 6 Treatment Methods

  • Fertility pharmaceuticals

  • Introduction and Types

  • Market revenue and forecasting

  • Future advances in infertility products

  • Competitive Analysis

Chapter 7 Assisted Reproductive Technologies

  • presentation

  • kind

  • IVF

  • Induction of ovulation

  • Oocyte Retrieval

  • Intracytoplasmic Sperm Injection (Icsi)

  • Fertilization

  • Embryo transfer

  • IVF results

  • Gift

  • Tar

  • Womb for rent

  • Donation of Oocytes

  • Frozen embryos

  • Fertility Clinics of the United States

  • Market revenue and forecasting

  • Future trends in assisted reproductive technology

  • Competitive Analysis Chapter 8 Fertility Diagnostics

  • presentation

  • kind

  • Urine studies

  • Market revenue and forecasting

  • Competitive Analysis

  • Future advances in diagnostic fertility treatment

  • Total Infertility Market Revenue and Forecast

Chapter 9 Contraception Market

  • Introduction and overview of contraception

  • pharmaceutics

  • kind

  • Other contraceptive drug regimens

  • Market revenue and forecasting

  • Competitive Analysis

  • Prescription devices

  • Market revenue and forecasting

  • Competitive Analysis

  • Future advances in contraception

  • Total market revenue and forecast

Chapter 10 The Sexual Dysfunction Market

  • Introduction and Overview

  • Types of sexual dysfunction

  • Causes of sexual dysfunction

  • Demographics of sexual dysfunction

  • pharmaceutics

  • Introduction and Types

  • Market revenue and forecasting

  • Competitive Analysis

  • Equipment

  • Market revenue and forecasting

  • Future advances in sexual dysfunction

  • Total market revenue and forecast

Chapter 11 Patents

Chapter 12 The Total Market

  • Total Global Market for Reproductive Technologies and Products, by Region

  • North America

  • Europe

  • Asia-Pacific

  • The rest of the world

  • Total market size by category

  • Industry participants by category

  • Total market size by product type

Chapter 13 The competitive landscape

Chapter 14 Company Profiles

  • Actavis, Inc.

  • Bayer AG

  • Bristol-Myers Squibb Co.

  • Church & Dwight Company Inc.

  • Coopersurgical Inc.

  • Eli Lilly & Co.

  • Emd Serono, Inc.

  • Ferring Pharmaceuticals

  • GlaxoSmithKline plc

  • Janssen Pharmaceuticals

  • Merck Inc.

  • Novartis International AG

  • Pfizer Inc.

  • Princeton Biomeditech Corp.

  • Quidel Corp.

  • Teva Pharmaceuticals.

  • Live Inc.

For more information about this report, visit

Media contact:

Research and markets
Laura WoodSenior manager
[email protected]

For EST office hours, call +1-917-300-0470
For US/CAN Call toll free +1-800-526-8630
For GMT office hours Call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside USA): +353-1-481-1716




View original content: 2022-and-cagr-projections-through-2027-301613040.html

SOURCE Research and Markets

Leave a Comment

Your email address will not be published. Required fields are marked *